BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 24908608)

  • 1. Naphthyridinone (NTD) integrase inhibitors 4. Investigating N1 acetamide substituent effects with C3 amide groups.
    Johns BA; Kawasuji T; Weatherhead JG; Boros EE; Thompson JB; Koble CS; Garvey EP; Foster SA; Jeffrey JL; Fujiwara T
    Bioorg Med Chem Lett; 2014 Jul; 24(14):3104-7. PubMed ID: 24908608
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Naphthyridinone (NTD) integrase inhibitors: N1 protio and methyl combination substituent effects with C3 amide groups.
    Johns BA; Kawasuji T; Weatherhead JG; Boros EE; Thompson JB; Koble CS; Garvey EP; Foster SA; Jeffrey JL; Fujiwara T
    Bioorg Med Chem Lett; 2013 Jan; 23(2):422-5. PubMed ID: 23245515
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and antiviral activity of 7-benzyl-4-hydroxy-1,5-naphthyridin-2(1H)-one HIV integrase inhibitors.
    Boros EE; Edwards CE; Foster SA; Fuji M; Fujiwara T; Garvey EP; Golden PL; Hazen RJ; Jeffrey JL; Johns BA; Kawasuji T; Kiyama R; Koble CS; Kurose N; Miller WH; Mote AL; Murai H; Sato A; Thompson JB; Woodward MC; Yoshinaga T
    J Med Chem; 2009 May; 52(9):2754-61. PubMed ID: 19374386
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis of 5-(1-H or 1-alkyl-5-oxopyrrolidin-3-yl)-8-hydroxy-[1,6]-naphthyridine-7-carboxamide inhibitors of HIV-1 integrase.
    Melamed JY; Egbertson MS; Varga S; Vacca JP; Moyer G; Gabryelski L; Felock PJ; Stillmock KA; Witmer MV; Schleif W; Hazuda DJ; Leonard Y; Jin L; Ellis JD; Young SD
    Bioorg Med Chem Lett; 2008 Oct; 18(19):5307-10. PubMed ID: 18774711
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combining symmetry elements results in potent naphthyridinone (NTD) HIV-1 integrase inhibitors.
    Johns BA; Kawasuji T; Weatherhead JG; Boros EE; Thompson JB; Garvey EP; Foster SA; Jeffrey JL; Miller WH; Kurose N; Matsumura K; Fujiwara T
    Bioorg Med Chem Lett; 2011 Nov; 21(21):6461-4. PubMed ID: 21945283
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A series of 5-aminosubstituted 4-fluorobenzyl-8-hydroxy-[1,6]naphthyridine-7-carboxamide HIV-1 integrase inhibitors.
    Guare JP; Wai JS; Gomez RP; Anthony NJ; Jolly SM; Cortes AR; Vacca JP; Felock PJ; Stillmock KA; Schleif WA; Moyer G; Gabryelski LJ; Jin L; Chen IW; Hazuda DJ; Young SD
    Bioorg Med Chem Lett; 2006 Jun; 16(11):2900-4. PubMed ID: 16554152
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Design, synthesis and SAR study of novel C2-pyrazolopyrimidine amides and amide isosteres as allosteric integrase inhibitors.
    Patel M; Cianci C; Allard CW; Parker DD; Simmermacher J; Jenkins S; Mcauliffe B; Minassian B; Discotto L; Krystal M; Meanwell NA; Naidu BN
    Bioorg Med Chem Lett; 2020 Nov; 30(21):127516. PubMed ID: 32860982
    [TBL] [Abstract][Full Text] [Related]  

  • 8. QSAR study of substituted 1,3,4-oxadiazole naphthyridines as HIV-1 integrase inhibitors.
    Ravichandran V; Shalini S; Sundram K; Sokkalingam AD
    Eur J Med Chem; 2010 Jul; 45(7):2791-7. PubMed ID: 20347187
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The naphthyridinone GSK364735 is a novel, potent human immunodeficiency virus type 1 integrase inhibitor and antiretroviral.
    Garvey EP; Johns BA; Gartland MJ; Foster SA; Miller WH; Ferris RG; Hazen RJ; Underwood MR; Boros EE; Thompson JB; Weatherhead JG; Koble CS; Allen SH; Schaller LT; Sherrill RG; Yoshinaga T; Kobayashi M; Wakasa-Morimoto C; Miki S; Nakahara K; Noshi T; Sato A; Fujiwara T
    Antimicrob Agents Chemother; 2008 Mar; 52(3):901-8. PubMed ID: 18160521
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Amide-containing diketoacids as HIV-1 integrase inhibitors: synthesis, structure-activity relationship analysis, and biological activity.
    Li H; Wang C; Sanchez T; Tan Y; Jiang C; Neamati N; Zhao G
    Bioorg Med Chem; 2009 Apr; 17(7):2913-9. PubMed ID: 19269185
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Design and synthesis of 8-hydroxy-[1,6]naphthyridines as novel inhibitors of HIV-1 integrase in vitro and in infected cells.
    Zhuang L; Wai JS; Embrey MW; Fisher TE; Egbertson MS; Payne LS; Guare JP; Vacca JP; Hazuda DJ; Felock PJ; Wolfe AL; Stillmock KA; Witmer MV; Moyer G; Schleif WA; Gabryelski LJ; Leonard YM; Lynch JJ; Michelson SR; Young SD
    J Med Chem; 2003 Feb; 46(4):453-6. PubMed ID: 12570367
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ethyl malonate amides: a diketo acid offspring fragment for HIV integrase inhibition.
    Serafin K; Mazur P; Bak A; Laine E; Tchertanov L; Mouscadet JF; Polanski J
    Bioorg Med Chem; 2011 Aug; 19(16):5000-5. PubMed ID: 21767953
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 3-Hydroxy-1,5-dihydro-pyrrol-2-one derivatives as advanced inhibitors of HIV integrase.
    Kawasuji T; Fuji M; Yoshinaga T; Sato A; Fujiwara T; Kiyama R
    Bioorg Med Chem; 2007 Aug; 15(16):5487-92. PubMed ID: 17560110
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 1,3,4-Oxadiazole substituted naphthyridines as HIV-1 integrase inhibitors. Part 2: SAR of the C5 position.
    Johns BA; Weatherhead JG; Allen SH; Thompson JB; Garvey EP; Foster SA; Jeffrey JL; Miller WH
    Bioorg Med Chem Lett; 2009 Mar; 19(6):1807-10. PubMed ID: 19217284
    [TBL] [Abstract][Full Text] [Related]  

  • 15. N-hydroxy-substituted 2-aryl acetamide analogs: A novel class of HIV-1 integrase inhibitors.
    Debnath U; Kumar P; Agarwal A; Kesharwani A; Gupta SK; Katti SB
    Chem Biol Drug Des; 2017 Oct; 90(4):527-534. PubMed ID: 28294572
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Repositioning HIV-1 integrase inhibitors for cancer therapeutics: 1,6-naphthyridine-7-carboxamide as a promising scaffold with drug-like properties.
    Zeng LF; Wang Y; Kazemi R; Xu S; Xu ZL; Sanchez TW; Yang LM; Debnath B; Odde S; Xie H; Zheng YT; Ding J; Neamati N; Long YQ
    J Med Chem; 2012 Nov; 55(22):9492-509. PubMed ID: 23098137
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The use of oxadiazole and triazole substituted naphthyridines as HIV-1 integrase inhibitors. Part 1: Establishing the pharmacophore.
    Johns BA; Weatherhead JG; Allen SH; Thompson JB; Garvey EP; Foster SA; Jeffrey JL; Miller WH
    Bioorg Med Chem Lett; 2009 Mar; 19(6):1802-6. PubMed ID: 19217781
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Triketoacid inhibitors of HIV-integrase: a new chemotype useful for probing the integrase pharmacophore.
    Walker MA; Johnson T; Ma Z; Banville J; Remillard R; Kim O; Zhang Y; Staab A; Wong H; Torri A; Samanta H; Lin Z; Deminie C; Terry B; Krystal M; Meanwell N
    Bioorg Med Chem Lett; 2006 Jun; 16(11):2920-4. PubMed ID: 16546383
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A naphthyridine carboxamide provides evidence for discordant resistance between mechanistically identical inhibitors of HIV-1 integrase.
    Hazuda DJ; Anthony NJ; Gomez RP; Jolly SM; Wai JS; Zhuang L; Fisher TE; Embrey M; Guare JP; Egbertson MS; Vacca JP; Huff JR; Felock PJ; Witmer MV; Stillmock KA; Danovich R; Grobler J; Miller MD; Espeseth AS; Jin L; Chen IW; Lin JH; Kassahun K; Ellis JD; Wong BK; Xu W; Pearson PG; Schleif WA; Cortese R; Emini E; Summa V; Holloway MK; Young SD
    Proc Natl Acad Sci U S A; 2004 Aug; 101(31):11233-8. PubMed ID: 15277684
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Benzyl amide-ketoacid inhibitors of HIV-integrase.
    Walker MA; Johnson T; Naidu BN; Banville J; Remillard R; Plamondon S; Martel A; Li C; Torri A; Samanta H; Lin Z; Dicker I; Krystal M; Meanwell NA
    Bioorg Med Chem Lett; 2007 Sep; 17(17):4886-90. PubMed ID: 17604626
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.